260
Views
0
CrossRef citations to date
0
Altmetric
Articles

Environmental asbestos exposure and nonmalignant pleural findings: a retrospective evaluation of a five-year chest CT repository

, , , , , & show all

References

  • Metintas S, Ak G, Metintas M. A review of the cohorts with environmental and occupational mineral fiber exposure. Arch Environ Occup Health. 2019;74(1-2):76–84. doi:10.1080/19338244.2018.1467873.
  • Nielsen LS, Baelum J, Rasmussen J, et al. Occupational Asbestos Exposure and Lung cancer-a systematic review of the literature. Arch Environ Occup Health. 2014;69(4):191–206. doi:10.1080/19338244.2013.863752.
  • Araki T, Yanagawa M, Sun FJ, et al. Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features. Occup Environ Med. 2017;74(10):756–761. doi:10.1136/oemed-2016-104178.
  • Mazzei MA, Contorni F, Gentili F, et al. Incidental and underreported pleural plaques at chest CT: do not miss them-asbestos exposure still exists. Biomed Res Int. 2017;2017:6797826. doi:10.1155/2017/6797826.
  • Silva M, Sverzellati N, Colombi D, et al. Pleural plaques in lung cancer screening by low-dose computed tomography: prevalence, association with lung cancer and mortality. BMC Pulm Med. 2017;17(1):155. doi:10.1186/s12890-017-0506-3.
  • Rapisarda V, Ledda C, Migliore M, et al. FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: a pilot study. Future Oncol. 2015;11(24s):35–37. doi:10.2217/fon.15.271.
  • Ledda C, Loreto C, Matera S, et al. Early effects of fluoro-edenite: correlation between IL-18 serum levels and pleural and parenchymal abnormalities. Future Oncol. 2016;12(23s):59–62. doi:10.2217/fon-2016-0338.
  • Kopylev L, Christensen KY, Brown JS, Cooper GS. A systematic review of the association between pleural plaques and changes in lung function. Occup Environ Med. 2015;72(8):606–614. doi:10.1136/oemed-2014-102468.
  • Pairon JC, Andujar P, Rinaldo M, et al. Asbestos exposure, pleural plaques, and the risk of death from lung cancer. Am J Respir Crit Care Med. 2014;190(12):1413–1420. doi:10.1164/rccm.201406-1074OC.
  • Ameille J, Brochard P, Letourneux M, Paris C, Pairon JC. Asbestos-related cancer risk in patients with asbestosis or pleural plaques. Rev Mal Respir. 2011;28(6):e11–e17. doi:10.1016/j.rmr.2011.04.008.
  • Paris C, Thierry S, Brochard P, the National APEXS Members, et al. Pleural plaques and asbestosis: dose- and time-response relationships based on HRCT data. Eur Respir J. 2009;34(1):72–79. doi:10.1183/09031936.00094008.
  • Arachi D, Furuya S, David A, et al. Development of the "National Asbestos Profile" to Eliminate Asbestos-Related Diseases in 195 Countries. Int J Environ Res Public Health. 2021;18(4):1804.
  • Ramazzini C. Asbestos is still with us: repeat call for a universal ban. Arch Environ Occup Health. 2010;65(3):121–126. doi:10.1080/19338241003776104.
  • Noonan CW. Environmental asbestos exposure and risk of mesothelioma. Ann Transl Med. 2017;5(11):234–234. doi:10.21037/atm.2017.03.74.
  • Ledda C, Loreto C, Pomara C, et al. Sheep lymph-nodes as a biological indicator of environmental exposure to fluoro-edenite. Environ Res. 2016;147:97–101. doi:10.1016/j.envres.2016.01.043.
  • Coplu L, Dumortier P, Demir AU, et al. An epidemiological study in an Anatolian village in Turkey environmentally exposed to tremolite asbestos. J Environ Pathol Toxicol Oncol. 1996;15:177–182.
  • Metintas S, Batirel HF, Bayram H, et al. Turkey national mesothelioma surveillance and environmental asbestos exposure control program. Int J Environ Res Public Health. 2017;14(11):1293.
  • Ates G, Yildiz T, Akyildiz L, Topcu F, Erturk B. Environmental asbestos-related pleural plaque in southeast of Turkey. Arch Environ Occup Health. 2010;65(1):34–37. doi:10.1080/19338240903390321.
  • Baris YI. Fibrous zeolite (erionite)-related diseases in Turkey. Am J Ind Med. 1991;19:374–378.
  • Dumortier P, Coplu L, de Maertelaer V, Emri S, Baris I, De Vuyst P. Assessment of environmental asbestos exposure in Turkey by bronchoalveolar lavage. Am J Respir Crit Care Med. 1998;158(6):1815–1824. doi:10.1164/ajrccm.158.6.9712119.
  • Okten F, Köksal D, Onal M, Ozcan A, Simşek C, Ertürk H. Computed tomography findings in 66 patients with malignant pleural mesothelioma due to environmental exposure to asbestos. Clin Imaging. 2006;30(3):177–180.
  • Erzen C, Eryilmaz M, Kalyoncu F, Bilir N, Sahin A, Baris YI. CT findings in malignant pleural mesothelioma related to nonoccupational exposure to asbestos and fibrous zeolite (erionite). J Comput Assist Tomogr. 1991;15(2):256–260. doi:10.1097/00004728-199103000-00012.
  • Şenyiğit A, Bayram H, Babayiğit C, et al. Malignant pleural mesothelioma caused by environmental exposure to asbestos in the Southeast of Turkey: CT findings in 117 patients. Respiration. 2000;67(6):615–622. doi:10.1159/000056290.
  • Vehmas T, Oksa P, Kivisaari L. Lung and pleural CT signs predict deaths: 10-year follow-up after lung cancer screening of asbestos-exposed workers. Int Arch Occup Environ Health. 2012;85(2):207–213. doi:10.1007/s00420-011-0654-3.
  • Larson TC, Meyer CA, Kapil V, et al. Workers with Libby amphibole exposure: retrospective identification and progression of radiographic changes. Radiology. 2010;255(3):924–933. doi:10.1148/radiol.10091447.
  • Kishimoto T, Morinaga K, Kira S. The prevalence of pleural plaques and/or pulmonary changes among construction workers in Okayama, Japan. Am J Ind Med. 2000;37(3):291–295. doi:10.1002/(SICI)1097-0274(200003)37:3<291::AID-AJIM7>3.0.CO;2-A.
  • Baris YI, Bilir N, Artvinli M, Sahin AA, Kalyoncu F, Sebastien P. An epidemiological study in an Anatolian village environmentally exposed to tremolite asbestos. Br J Ind Med. 1988;45(12):838–840. doi:10.1136/oem.45.12.838.
  • American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004;170:691–715.
  • Bayram M, Ozkan D, Hayat E, et al. Asbestos-related diseases in Turkey: caused not only by naturally occurring fibers but also by industrial exposures. Am J Respir Crit Care Med. 2019;199(5):656–659. doi:10.1164/rccm.201810-1922LE.
  • Bayram M, Dongel I, Bakan ND, et al. High risk of malignant mesothelioma and pleural plaques in subjects born close to ophiolites. Chest. 2013;143(1):164–171. doi:10.1378/chest.11-2727.
  • Kwak K, Zoh KE, Paek D. Incidence of cancer and asbestos-related diseases among residents living near abandoned asbestos mines in South Korea: a retrospective cohort study using national health insurance database. IJERPH. 2021;18(3):875. doi:10.3390/ijerph18030875.
  • Alfudhili KM, Lynch DA, Laurent F, Ferretti GR, Dunet V, Beigelman-Aubry C. Focal pleural thickening mimicking pleural plaques on chest computed tomography: tips and tricks. Br J Radiol. 2016;89(1057):20150792. doi:10.1259/bjr.20150792.
  • Kim Y, Myong JP, Lee JK, Kim JS, Kim YK, Jung SH. CT characteristics of pleural plaques related to occupational or environmental asbestos exposure from South Korean asbestos mines. Korean J Radiol. 2015;16(5):1142–1152. doi:10.3348/kjr.2015.16.5.1142.
  • Wolff H, Vehmas T, Oksa P, Rantanen J, Vainio H. Asbestos, asbestosis, and cancer, the Helsinki criteria for diagnosis and attribution 2014: recommendations. Scand J Work Environ Health. 2015;41(1):5–15. doi:10.5271/sjweh.3462.
  • Swiatkowska B, Szeszenia-Dabrowska N, Wilczynska U. Medical monitoring of asbestos-exposed workers: experience from Poland. Bull World Health Organ. 2016;94:599–604.
  • Diego Roza C, Cruz Carmona MJ, Fernandez AR, et al. Recommendations for the diagnosis and management of asbestos-related pleural and pulmonary disease. Arch Bronconeumol. 2017;53(8):437–442. doi:10.1016/j.arbres.2016.12.014.
  • Chellini E, Battisti F, Cristaudo A, Sartorelli P, Cala P. Health surveillance for former asbestos exposed worker: a specific programme developed in an Italian region. J Thorac Dis. 2018;10(Suppl 2):S383–S389. doi:10.21037/jtd.2017.10.84.
  • Wild CP. Complementing the genome with an "exposome": the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1847–1850. doi:10.1158/1055-9965.EPI-05-0456.
  • DeBord DG, Carreón T, Lentz TJ, Middendorf PJ, Hoover MD, Schulte PA. Use of the "exposome" in the practice of epidemiology: a primer on -omic technologies. Am J Epidemiol. 2016;184(4):302–314. doi:10.1093/aje/kwv325.
  • Niedzwiecki MM, Walker DI, Vermeulen R, Chadeau-Hyam M, Jones DP, Miller GW. The Exposome: Molecules to Populations. Annu Rev Pharmacol Toxicol. 2019;59:107–127. doi:10.1146/annurev-pharmtox-010818-021315.
  • Slama R, Vrijheid M. Some challenges of studies aiming to relate the Exposome to human health. Occup Environ Med. 2015;72(6):383–384. doi:10.1136/oemed-2014-102546.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.